Impact of Pharmaceutical Care in Diabetics Patients (IPCD)
The monitoring of diabetics by the pharmacist may contribute to the effectiveness of drug treatment and to improve their quality of life. This study will measure the impact of pharmacotherapeutic follow-up in diabetic patients. This will be a clinical trial, single blind, controlled, randomized, conducted in two units of pharmacies in Brazil. Only in the intervention group will be held the pharmacotherapeutic follow using a methodology called the practice of pharmaceutical care, which identifies and resolves problems related to drugs. The primary outcome is glycated hemoglobin, and secondary outcomes are baseline glucose, total cholesterol and its fractions LDL, HDL and VLDL, all these measures will be made in the intervention group and control group. Patients will be followed for 24 weeks, and the outcomes will be assessed up to 24 weeks. There will be a confidence interval of 95% and a significance of p <0.05, and will use the Student t test, chi-square analysis of variance (ANOVA) and others if necessary. Expects good results and serve as a model for other researchers.
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind (Caregiver)
Primary Purpose: Treatment
|Official Title:||Popular Pharmacy of Brazil: Impact of Pharmaceutical Care in Diabetics Patients|
- glycated hemoglobin [ Time Frame: Up to 24 weeks ] [ Designated as safety issue: No ]
- blood glucose [ Time Frame: Up to 24 weeks ] [ Designated as safety issue: No ]
- total cholesterol [ Time Frame: Up to 24 weeks ] [ Designated as safety issue: No ]
- fractions of HDL, LDL and VLDL cholesterol [ Time Frame: Up to 24 weeks ] [ Designated as safety issue: No ]
|Study Start Date:||September 2009|
|Study Completion Date:||December 2011|
|Primary Completion Date:||December 2011 (Final data collection date for primary outcome measure)|
No Intervention: control group
Patients will not be followed by the pharmacist.
Experimental: Intervention group
Patients will be followed by the pharmacist.
Behavioral: Intervention: Pharmaceutical Care
Patients will be followed by the pharmacist by the Pharmaceutical Care Practice
|Universidade Estadual da Paraíba|
|João Pessoa, Paraíba, Brazil|
|Study Director:||Ivonete Araújo Doutorado||Universidade Federal do Rio Grande do Norte|